Scholar Rock Holding Corporation will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 4. The company is focused on developing apitegromab for patients with spinal muscular atrophy and other neuromuscular diseases. CEO David L. Hallal and the management team will represent the company at the event.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scholar Rock Holding Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250528248244) on May 28, 2025, and is solely responsible for the information contained therein.